Incidence of Inflammatory Bowel Disease in South Asian and Chinese People: A Population-Based Cohort Study from Ontario, Canada
- PMID: 34876857
- PMCID: PMC8643128
- DOI: 10.2147/CLEP.S336517
Incidence of Inflammatory Bowel Disease in South Asian and Chinese People: A Population-Based Cohort Study from Ontario, Canada
Abstract
Background: Inflammatory bowel disease (IBD) is now a global disease with incidence increasing throughout Asia.
Aim: To determine the incidence of IBD among South Asians and Chinese people residing in Ontario, Canada's most populous province.
Methods: All incident cases of IBD in children (1994-2015) and adults (1999-2015) were identified from population-based health administrative data. We classified South Asian and Chinese ethnicity using immigration records and surnames. We determined standardized incidence of IBD and adjusted incidence rate ratio (aIRR) in South Asians and Chinese compared to the general population.
Results: Among 16,230,638 people living in Ontario, standardized incidence of IBD per 100,000 person-years was 24.7 (95% CI 24.4-25.0), compared with 14.6 (95% CI 13.7-15.5) in 982,472 South Asians and with 5.4 (95% CI 4.8-5.9) in 764,397 Chinese. The risk of IBD in South Asians was comparable to the general population after adjusting for immigrant status and confounders (aIRR 1.03, 95% CI 0.96-1.10). South Asians had a lower risk of Crohn's disease (CD) (aIRR 0.66, 95% CI 0.60-0.77), but a higher risk of ulcerative colitis (UC) (aIRR 1.47, 95% CI 1.34-1.61). Chinese people had much lower rates of IBD (aIRR 0.24, 95% CI 0.20-0.28), CD (aIRR 0.21, 95% CI 0.17-0.26), and UC (aIRR 0.28, 95% CI 0.23-0.25).
Conclusion: Canadians of South Asian ethnicity had a similarly high risk of developing IBD compared to other Canadians, and a higher risk of developing UC, a finding distinct from the Chinese population. Our findings indicate the importance of genetic and environmental risk factors in people of Asian origin who live in the Western world.
Keywords: Chinese; Crohn’s disease; South Asian; epidemiology; ethnicity; incidence; inflammatory bowel disease; ulcerative colitis.
© 2021 Dhaliwal et al.
Conflict of interest statement
No conflicts to declare: Jasbir Dhaliwal, Emily Herrett, Meltem Tuna, Sanjay Murthy, Baiju Shah. AMG: Anne Griffiths – Consultant: AbbVie, Merck, Janssen, Eli Lilly, Pfizer, Gilead, Roche, Takeda; Speaker: AbbVie, Janssen, Shire; Investigator-initiated research support: AbbVie. EIB: Eric Benchimol has acted as a legal consultant for Hoffman La-Roche Limited and Peabody & Arnold LLP for matters unrelated to a medication used to treat inflammatory bowel disease. Dr. Benchimol also acted as a consultant for McKesson Canada. The authors report no other conflicts of interest in this work. The Data Accessed Complies with Relevant Data Protection and Privacy Regulations.
Figures


Similar articles
-
The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology.J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S6-S16. doi: 10.1093/jcag/gwy054. Epub 2018 Nov 2. J Can Assoc Gastroenterol. 2019. PMID: 31294381 Free PMC article.
-
Asthma, type 1 and type 2 diabetes mellitus, and inflammatory bowel disease amongst South Asian immigrants to Canada and their children: a population-based cohort study.PLoS One. 2015 Apr 7;10(4):e0123599. doi: 10.1371/journal.pone.0123599. eCollection 2015. PLoS One. 2015. PMID: 25849480 Free PMC article.
-
Spatial cluster mapping and environmental modeling in pediatric inflammatory bowel disease.World J Gastroenterol. 2023 Jun 21;29(23):3688-3702. doi: 10.3748/wjg.v29.i23.3688. World J Gastroenterol. 2023. PMID: 37398882 Free PMC article.
-
Epidemiology of inflammatory bowel disease in South America: A systematic review.World J Gastroenterol. 2019 Dec 21;25(47):6866-6875. doi: 10.3748/wjg.v25.i47.6866. World J Gastroenterol. 2019. PMID: 31885427 Free PMC article.
-
Inflammatory bowel disease: a survey of the epidemiology in Asia.J Dig Dis. 2009 Feb;10(1):1-6. doi: 10.1111/j.1751-2980.2008.00355.x. J Dig Dis. 2009. PMID: 19236540 Review.
Cited by
-
The epidemiology of inflammatory bowel disease: Clues to pathogenesis?Front Pediatr. 2023 Jan 17;10:1103713. doi: 10.3389/fped.2022.1103713. eCollection 2022. Front Pediatr. 2023. PMID: 36733765 Free PMC article. Review.
-
The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries.United European Gastroenterol J. 2022 Dec;10(10):1063-1076. doi: 10.1002/ueg2.12350. Epub 2022 Dec 8. United European Gastroenterol J. 2022. PMID: 36479863 Free PMC article. Review.
-
Unveiling the fungal frontier: mycological insights into inflammatory bowel disease.Front Immunol. 2025 Mar 26;16:1551289. doi: 10.3389/fimmu.2025.1551289. eCollection 2025. Front Immunol. 2025. PMID: 40207229 Free PMC article. Review.
-
Inflammatory bowel disease: a narrative review of disease evolution in South Asia and India over the last decade.Therap Adv Gastroenterol. 2024 Nov 20;17:17562848241258360. doi: 10.1177/17562848241258360. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 39575157 Free PMC article. Review.
-
Neutrophils: From Inflammatory Bowel Disease to Colitis-Associated Colorectal Cancer.J Inflamm Res. 2025 Jan 22;18:925-947. doi: 10.2147/JIR.S497701. eCollection 2025. J Inflamm Res. 2025. PMID: 39871958 Free PMC article. Review.
References
-
- 2016 census highlights ethnic origin and visible minorities, factsheet 9; 2016.
-
- 2016 census highlights immigration, factsheet 8; 2016.
LinkOut - more resources
Full Text Sources